Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVc Influenza Vaccine in Healthy Children (6-48 Months)
NCT02035696Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of trivalent influenza vaccine in influenza, sponsored by CSL Seqirus. Started Dec 2013; status: completed.
02
Drugs
trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02035696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035696.